Dr. Maytin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 216-444-2200Fax+1 216-444-9198
Education & Training
- Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 1986 - 1990
- Brown UniversityInternship, Internal Medicine, 1985 - 1986
- University of Rochester School of Medicine and DentistryClass of 1985
Certifications & Licensure
- CA State Medical License 1990 - Present
- OH State Medical License 2000 - 2026
- MA State Medical License 1990 - 2011
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer Start of enrollment: 2008 Mar 01
- Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses Start of enrollment: 2014 Apr 01
- Blue vs Red Light During Levulan Based Photodynamic Therapy in Patients With Basal Cell Nevus Syndrome Start of enrollment: 2016 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 97 citationsPegylation of a Chlorine6 Polymer Conjugate Increases Tumor Targeting of PhotosensitizerMichael R. Hamblin, Jaimie L. Miller, Imran Rizvi, Bernhard Ortel, Edward V. Maytin
Cancer Research. 2001-10-01 - 39 citationsEUS-guided verteporfin photodynamic therapy for pancreatic cancerYuri Hanada, Stephen P. Pereira, Brian W. Pogue, Edward V. Maytin, Tayyaba Hasan
Gastrointestinal Endoscopy. 2021-07-01 - 196 citationsStress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms.Edward V. Maytin, Mariano Ubeda, Julia C. Lin, Joel F. Habener
Experimental Cell Research. 2001-07-15
Press Mentions
- Dermatologists Combine Two Effective Treatments for Precancerous Actinic KeratosesSeptember 13th, 2018
- Expanding Our Options for Treating Actinic KeratosesJanuary 26th, 2021
Grant Support
- Small Molecule Enhancers Of Photodynamic Therapy For Skin CancerNational Cancer Institute2009–2012
- Hyaluronan (HA) As A Regulator Of Inflammation And FibrosisNational Heart, Lung, And Blood Institute2011
- Combination Therapy With 5-FU And PDT For The Treatment Of Post-Transplant PremalNational Cancer Institute2011
- Hyaluronan In Epidermal Injury ResponsesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2009
- Hyaluronan And Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2007
- Role Of Cellular DifferentiationNational Cancer Institute2001–2002
- C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
- C/Edb Beta And CHOP In Epidermal DifferentiationNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1998–1999
- Regulation Of The K10 Gene By C/Ebps In KeratinocytesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1995–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: